At the starting dose of 0.25 mg, most researchers lose 2 to 6 pounds during the first four weeks
Supply could increase more significantly years from now: Novo Nordisk in November said it would invest $6 billion to expand its manufacturing facilities in Denmark, noting it will finish construction from the end of 2025 through 2029
This article was written as a guest article by our friend, JCanNuSH (@JCanNush on X) While many of the big moments at the ADA 2026 Scientific Sessions will involve upcoming medications like retatrutide, CagriSema, mazdutide, or UBT251, there are several potential advancements in medication delivery being presented that are worth noting
If your priority is speed and simplicity over formulation variety, Direct Meds may be a better fit
Contribution statement All authors significantly contributed to the manuscript
Because of its therapeutic effects, pharmaceutical companies have developed drugs that mimic GLP-1s effects to treat obesity, prediabetes, and type 2 diabetes mellitus